
Company Info
Year Established2017
Contacts
Saul Kato, PhDCo-Founder & CEO
Company Description
Herophilus is a neurotherapeutics development company that employs AI-driven phenotypic screening to discover and develop novel drugs for complex brain diseases, disorders for which traditional discovery techniques have proved least successful.